Abstract
Tissue factor (TF) has been implicated in the thrombotic complications seen during vascular rejection of allografts and may contribute to intimal hyperplasia in chronic allograft vasculopathy. Downregulation of endothelial TF expression post-transplantation could therefore be of therapeutic value. Lentivirus-mediated RNA interference was used in primary endothelial cells (EC) to investigate its effects on TF protein expression and functional activity. Lentivirus-mediated expression of a TF-specific short-interfering (si) RNA with green fluorescent protein as a reporter gene (siRNATF-GFP) resulted in a 42 ± 3.9% reduction in EC surface-expressed TF as compared with cells expressing a scrambled siRNATF sequence (P = 0.025). The TF content in EC lysates was reduced from 6.85 ± 1.99 ng to 3.05 ± 0.82 ng (P = 0.006). Factor X (FX) activation was not impaired on the apical EC surface. The subendothelial matrix of ECs with low TF expression showed significantly reduced TF activity compared with non-transduced cells or with cells harboring the empty vector. ECs expressing siRNATF-GFP exhibited reduced reporter gene (GFP) expression and cell density and an altered morphology. Transfection of control cells with high (J82 cells) or low (MiaPaCa-2 cells) TF expression with siRNATF oligonucleotides caused apoptosis of the J82 but not of the MiaPaCa-2 cells. Thus, lentivirus-mediated RNA interference reduces the TF expression of activated ECs but does not affect FX activation by TF/FVIIa expressed on the apical surface. The downregulation has nevertheless substantial negative effects on the viability of ECs and TF-expressing control cells. These findings imply that certain levels of TF are required for the maintained viability and growth of endothelium and TF-expressing tumor cells.
Similar content being viewed by others
References
Amarzguioui M, Peng Q, Wiiger MT, Vasovic V, Babaie E, Holen T, et al (2006) Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin Cancer Res 12:4055–4061
Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, et al (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10:502–509
Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MAJ (1986) Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 83:4533–4537
Bokarewa MI, Tarkowski A (2001) Thrombin generation and mortality during Staphylococcus aureus sepsis. Microb Pathog 30:247–252
Bokarewa MI, Morrissey JH, Tarkowski A (2002) Tissue factor as a proinflammatory agent. Arthritis Res 4:190–195
Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH (1999) Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost 82:88–92
Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, et al (1996) Role of tissue factor in embryonic blood vessel development. Nature 383:73–75
Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, et al (1983) Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 71:1893–1896
Contrino J, Hair G, Kreutzer DL, Rickles FR (1996) In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 2:209–215
Ehrnfelt C, He Z, Holgersson J (2005) No role of alpha-Gal in human monocyte-endothelial cell interactions in vitro. Scand J Immunol 62:445–452
Golino P, Ragni M, Cirillo P, Avvedimento VE, Feliciello A, Esposito N, et al (1996) Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. Nat Med 2:35–40
He Z, Ehrnfelt C, Kumagai-Braesch M, Islam KB, Holgersson J (2004) Aberrant expression of alpha-Gal on primary human endothelium does not confer susceptibility to NK cell cytotoxicity or increased NK cell adhesion. Eur J Immunol 34:1185–1195
Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res 30:1757–1766
Jang Y, Guzman LA, Lincoff AM, Gottsauner-Wolf M, Forudi F, Hart CE, et al (1995) Influence of blockade at specific levels of the coagulation cascade on restenosis in a rabbit atherosclerotic femoral artery injury model. Circulation 92:3041–3050
Ketting RF, Haverkamp TH, Luenen HG van, Plasterk RH (1999) Mut-7 of C. elegans, required for transposon silencing and RNA interference, is a homolog of Werner syndrome helicase and RNaseD. Cell 99:133–141
Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, Yanagihara K, et al (2005) Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 11:2531–2539
Osterholm C, Qi Z, Ekberg J, Veress B, Pyke C, Hedner U, et al (2001) Initial inhibition of tissue factor signalling reduces chronic vascular changes in isogenic rat aortic transplants. Am J Transplant 1:29–37
Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W (1998) A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol 140:1241–1253
Parry GC, Erlich JH, Carmeliet P, Luther T, Mackman N (1998) Low levels of tissue factor are compatible with development and hemostasis in mice. J Clin Invest 101:560–569
Pawlinski R, Fernandes A, Kehrle B, Pedersen B, Parry G, Erlich J, et al (2002) Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci USA 99:15333–15338
Pyo RT, Sato Y, Mackman N, Taubman MB (2004) Mice deficient in tissue factor demonstrate attenuated intimal hyperplasia in response to vascular injury and decreased smooth muscle cell migration. Thromb Haemost 92:451–458
Ryan J, Brett J, Tijburg P, Bach RR, Kisiel W, Stern D (1992) Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surface. Blood 80:966–974
Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W (1989) Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem 264:9980–9988
Sato Y, Asada Y, Marutsuka K, Hatakeyama K, Kamikubo Y, Sumiyoshi A (1997) Tissue factor pathway inhibitor inhibits aortic smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Haemost 78:1138–1141
Sorensen BB, Persson E, Freskgard PO, Kjalke M, Ezban M, Williams T, et al (1997) Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor. J Biol Chem 272:11863–11868
Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr (1996) Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 88:1583–1587
Waterhouse PM, Wang MB, Lough T (2001) Gene silencing as an adaptive defence against viruses. Nature 411:834–842
Yan SF, Zou YS, Gao Y, Zhai C, Mackman N, Lee SL, et al (1998) Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci USA 95:8298–8303
Yang Y, Loscalzo J (2000) Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation 101:2144–2148
Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, Weitz JI, et al (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105:1734–1741
Acknowledgements
We thank Dr. Kjell Hultenby for excellent electron microscopy, Dr. Feng Wang for providing the MiaPaCa-2 cells, and Prof. D. Trono for providing the lentiviral vectors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by the Swedish Research Council (K2005-06X-13031-07A and K2005-06BI-15356-01A), the Professor Lars-Erik Gelin Foundation, the Tobias Foundation, the Swedish Diabetes Association, and an educational grant from Novo Nordisk.
Rights and permissions
About this article
Cite this article
Österholm, C., Li, S., Ekberg, H. et al. Downregulation of tissue factor (TF) by RNA interference induces apoptosis and impairs cell survival of primary endothelium and tumor cells. Cell Tissue Res 334, 93–102 (2008). https://doi.org/10.1007/s00441-008-0650-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-008-0650-4